Ibrutinib proves active in high-risk CLLJanuary 6, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Drug gets orphan designation for WMJanuary 4, 2015Lymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
Certain cancers primarily result from ‘bad luck’January 3, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersRelated IssuesAMLNon-Hodgkin Lymphoma
New data added to obinutuzumab labelJanuary 1, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
Approach can cure even high-risk FL, study suggestsDecember 23, 2014Lymphoma & Plasma Cell DisordersTransplantationNon-Hodgkin Lymphoma
Antibody shows activity in relapsed/refractory NHLDecember 11, 2014Lymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Drug gets orphan designation for MM & CLL/SLLDecember 3, 2014Lymphoma & Plasma Cell DisordersMultiple MyelomaPharmacyNon-Hodgkin Lymphoma
EZH2 inhibitor is active in NHL with wild-type EZH2November 21, 2014Lymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Chemo and CAR T cells prompt responses in NHLAugust 26, 2014Lymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Combo appears safe and active in CLL, NHLJuly 23, 2014Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Drug approved to treat NHL in IsraelJuly 23, 2014Lymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
Study validates drug’s efficacy in CLL/SLLJuly 3, 2014Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Ofatumumab falls short in CLL, DLBCLJune 29, 2014Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
Approach can reduce drug-induced TLSJune 18, 2014Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Drug gains orphan designation for DLBCLMay 22, 2014Lymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma